Knoll Capital Management’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12.6M | Buy |
|
|||||
|
2025
Q1 | $20M | Buy |
|
|||||
|
2024
Q4 | $28.4M | Buy |
|
|||||
|
2024
Q3 | $35.5M | Hold |
|
|||||
|
2024
Q2 | $24.7M | Buy |
|
|||||
|
2024
Q1 | $26.8M | Hold |
|
|||||
|
2023
Q4 | $21M | Hold |
|
|||||
|
2023
Q3 | $12.8M | Buy |
|
|||||
|
2023
Q2 | $10.8M | Hold |
|
|||||
|
2023
Q1 | $6.15M | Hold |
|
|||||
|
2022
Q4 | $6.25M | Sell |
|
|||||
|
2022
Q3 | $136M | Hold |
|
|||||
|
2022
Q2 | $131M | Hold |
|
|||||
|
2022
Q1 | $107M | Buy |
|
|||||
|
2021
Q4 | $124M | Buy |
|
|||||
|
2021
Q3 | $119M | Hold |
|
|||||
|
2021
Q2 | $83.2M | Hold |
|
|||||
|
2021
Q1 | $58.6M | Sell |
|
|||||
|
2020
Q4 | $73.5M | Hold |
|
|||||
|
2020
Q3 | $55.7M | Hold |
|
|||||
|
2020
Q2 | $62.1M | Hold |
|
|||||
|
2020
Q1 | $29.2M | Hold |
|
|||||
|
2019
Q4 | $46.6M | Hold |
|
|||||
|
2019
Q3 | $35.8M | Buy |
|
|||||
|
2019
Q2 | $32.8M | Hold |
|
|||||
|
2019
Q1 | $38.6M | Hold |
|
|||||
|
2018
Q4 | $27.7M | Hold |
|
|||||
|
2018
Q3 | $27.9M | Hold |
|
|||||
|
2018
Q2 | $29.6M | Hold |
|
|||||
|
2018
Q1 | $19.3M | Sell |
|
|||||
|
2017
Q4 | $21.8M | Hold |
|
|||||
|
2017
Q3 | $30.1M | Hold |
|
|||||
|
2017
Q2 | $20.2M | Buy |
|